Pfizer

EpiPen Maker Neglected ‘Hundreds’ of Complaints About Defects
Bloomberg
Thu, 09/7/17 - 05:41 pm
EpiPens
Mylan Labs
Pfizer
Meridian Medical Technologies
Pfizer puts hemophilia spin on ultrapopular Minecraft to educate young patients
Fierce Pharma
Wed, 09/6/17 - 08:42 pm
Pfizer
hemophilia
patients
Allergan-Restasis Patent Battle Could Test Lawmakers' Resolve
NY Shock Exchange
Wed, 09/6/17 - 09:11 am
Allergan
Restasis
patents
Mylan Labs
Pfizer
Teva Pharmaceutical
Shire
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
FDA Approves Pfizer’s Mylotarg 7 Years After it was Pulled From the Market
RAPS.org
Fri, 09/1/17 - 04:06 pm
Pfizer
FDA
Mylotarg
acute myeloid leukemia
AML
Bristol-Myers, Pfizer continue to build case for Eliquis
BioPharma Dive
Tue, 08/29/17 - 09:49 am
Bristol-Myers Squibb
Pfizer
Eliquis
blood thinners
Top 25 vaccine products in 2016, based on U.S. sales
Medical Marketing and Media
Mon, 08/28/17 - 10:33 pm
vaccines
Pfizer
Merck
Sanofi
Prevnar 13
Gardasil
Fluzone
Varivax
Menactra
Best Pharma Stocks Based on R&D Spending
Motley Fool
Mon, 08/28/17 - 09:27 am
R&D
pharma stocks
Roche
Novartis
Pfizer
JNJ
Merck
Pfizer's hunt for new Manhattan HQ lands on snazzy Spiral skyscraper: report
Fierce Pharma
Fri, 08/25/17 - 11:38 am
Pfizer
Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?
Fierce Pharma
Thu, 08/24/17 - 05:11 pm
Novartis
Kisqali
Pfizer
Ibrance
reimbursement
breast cancer
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status
Fierce Pharma
Wed, 08/23/17 - 11:21 am
Pfizer
Eucrisa
DTC
eczema
Dupixent
Sanofi
Regeneron
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Yahoo/Zacks.com
Wed, 08/23/17 - 11:14 am
Pfizer
Ibrance
breast cancer
Faslodex
AstraZeneca
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
RAPS.org
Tue, 08/22/17 - 06:43 pm
Pfizer
India
Prevnar 13
vaccine
patents
Pfizer's Besponsa Is Yet Another Win for the Biopharma Giant
Motley Fool
Sun, 08/20/17 - 11:54 am
Pfizer
Besponsa
acute lymphoblastic leukemia
FDA
Here's How Much $10,000 Invested in Pfizer in 1977 Is Worth Now
Motley Fool
Sun, 08/20/17 - 11:52 am
Pfizer
An analysis of 2017 first half for pharmaceutical industry
GoInPharma
Sat, 08/19/17 - 10:51 am
pharma industry
Pfizer
Sanofi
GSK
Roche
Celgene
Bristol-Myers Squibb
The FDA Just Approved a New Pfizer Cancer Drug for a Rare, Vicious Leukemia
Yahoo/Fortune
Fri, 08/18/17 - 04:27 pm
FDA
Pfizer
Besponsa
acute lymphoblastic leukemia
Can Pfizer Bank on New Immunotherapy Bavencio for Growth?
Yahoo/Zacks.com
Fri, 08/18/17 - 12:01 am
Pfizer
Bavencio
immuno-oncology
renal cell carcinoma
lung cancer
ovarian cancer
head and neck cancer
Pfizer’s CD22-targeted cancer drug inotuzumab wins an accelerated OK at FDA
Endpoints
Thu, 08/17/17 - 11:52 pm
Pfizer
inotuzumab ozogamicin
acute lymphoblastic leukemia
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan

Pages